Candida organisms are common saprophytes which reside on the skin and mucous membranes of the gastrointestinal tract in healthy persons, and in the vagina of pregnant and diabetic women. This fungus is ordinarily a weak pathogen which produces mild superficial infection, but occasionally it may cause a systemic disease with involvement of the lung, kidney, endocardium, brain, or reticuloendothelial system. In almost all instances of acute disseminated candidiasis the defence mechanisms of the host have been reduced by predisposing factors such as prior antibiotic therapy (Seelig, 1966) , systemic adrenocortical isteroids (Louria, Stiff, and Bennett, 1962) , indwelling intravascular catheters (Louria et al., 1962) , diabetes mellitus, and other serious chronic diseases. In addition, various neoplastic diseases such as lymphoma and Hodgkin's disease (Casazza, Duvall, and Carbone, 1966) favour the development of Candida infection and dissemination, but even in these diseases the development of systemic candidiasis was a rare event before modern therapy with bone marrow suppressants, antibiotics, steroids, and roentgen irradiation (Friedman, 1965) .
A case report is presented of a patient afflicted with three episodes of systemic Candida albicans infection, the last of which primarily involved her central nervous system. All three episodes occurred without underlying debilitating disease HOSPITAL COURSE After positive identification of a fungal infection by brain biopsy, intravenous amphotericin B was started with an initial dose of 10 mg and gradually increased to a dose of 30 to 50 mg every other day. By the seventh hospital day she had developed global aphasia and complete right upper extremity paralysis. By the 18th hospital day she had received a total of 430 mg intravenous amphotericin and her blood urea nitrogen had risen to 36 mg/100 ml. An Ommaya reservoir was inserted into the right lateral ventricle of the brain to permit direct injection of amphotericin into the central nervous system. An initial dose of 1 mg amphotericin was injected through this reservoir. Several hours later the patient developed diaphoresis, vomited, and within 12 hours she was in a deep coma. Throughout the next few days she showed signs of increasing intracranial pressure which did not improve with systemic steroid therapy. She died on the 21st hospital day. Before her death, the patient's peripheral white blood cells were stained with benzidine nitroprusside to determine the presence of the enzyme myeloperoxidase (Washburn, 1928 Horizontal sections through the cerebral hemispheres revealed a large ill-defined, soft mass 8 cm in diameter, in the left mid and posterior parietal region. The mass was filled with yellow necrotic material and in its posterior region a haemorrhage, 3 cm in diameter, was noted. The mass did not extend to the surface of the cortex, but did invade and obliterate part of the left lateral ventricle. Small multiple haemorrhages could be seen throughout sections of the pons and midbrain.
Microscopic sections of the leptomeninges at the base of the brain revealed an acute inflammatory reaction with infiltration of polymorphonuclear leukocytes, but no granuloma or PAS positive fungi were seen. Haematoxylin and eosin stains of sections through the brain abscess showed focal caseation necrosis with multinucleated giant cells and scattered neutrophilic debris (Fig. 3) . Candida in the form of yeast and mycelia were demonstrated in these areas with the use of PAS stains (Fig. 4) (Miale, 1943; Zimmerman, Frutchey, and Gibbes, 1947; Craig and Gates, 1949; Parrillo, 1950; Levi and Rezza, 1950; Janke, 1957; Vorreith, Bares, Benes, and Vancunik, 1961) . In the entire group of 42, there was a greater than 2 to 1 predominance of men. The age distribution showed one particularly interesting feature. Twelve patients were infants less than 1 month of age. Other authors (Seelig, 1966; Lederer and Todd, 1949) also reported the increased incidence of systemic candidiasis in the newborn infant. In most instances the source of the infection is from the birth canal, and the disease is felt to stem from the fact that newborn infants have immature immune mechanisms. In the remaining 30 patients there were eight in the first decade, three in the second, seven in the third, four in the fourth, two in the fifth, four in the sixth, and two in the seventh decade. The oldest patient was 68 years old.
The cerebrospinal fluid findings are similar to those of pyogenic bacterial meningitis. The cell count ranged from 0 to 22,560 cu. mm (Nalenz and Boese, 1951) , with a preponderance of neutrophils. The spinal fluid sugar may be low or normal. The protein is usually elevated and may reach as high as 940 mg/100 ml. (Ingomar and Terslev, 1964) . The spinal fluid cultures were positive for Candida albicans in nearly all the cases of meningitis. In contrast, identification of the fungus in the spinal fluid was more difficult in those patients who had brain abscess without involvement of the meninges. Therefore, the only definitive diagnostic procedure in patients with abscess or granuloma was surgical biopsy. In the four cases (including the present patient) in whom brain biopsy was performed, either by craniotomy or through trephine site, a specimen was obtained and the organism was identified as Candida albicans (Craig and Gates, 1949; Luyendijk, Welman, and Cormane, 1959; Vorreith et al., 1961) .
The prognosis in cerebral candidiasis differs depending upon the nature and the site of the infection. DeVita et al. (1966) stated that the survival rate in patients with meningitis before the use of amphotericin B was 68 %, and 83 % after the advent of this drug. In our review of the literature, 18 of 27 patients with meningitis survived. In contrast, only one of 16 patients (including the present patient) with brain abscess or granuloma lived more than four months after the diagnosis was made (Luyendijk et al., 1959) . There are a number of reasons for the poor prognosis in patients with cerebral involvement. As mentioned above, the cerebrospinal fluid cultures are frequently negative, the symptoms and signs of brain abscess are often vague, and there may be little extracranial fungal involvement to provide a useful clue for the diagnosis. Therefore, most cases of cerebral candidiasis are unsuspected during life or are diagnosed during the terminal stages of the associated illness.
Detailed neurological descriptions have been scarce. As suggested by the pathology, signs and symptoms referable to the cerebral cortex or cerebellum may dominate the clinical picture. In our patient, aphasia, hemiparesis, focal seizure, and papilloedema suggested the presence of an intracranial mass. Headache, photophobia, nuchal rigidity, and delirium may dominate the symptoms and signs in patients with meningitis.
PATHOLOGY AND PATHOGENESIS The kidney is the organ most commonly involved in systemic candidiasis and death is usually secondary to kidney failure (Louria, Stiff, and Bennett, 1962) . Next affected are the heart, lung, gastrointestinal tract, spleen, and brain in that order (Louria et al., 1962) . Candida usually reaches the brain by the haematogenous route and its usual portal of entry into the circulation is through the gastrointestinal tract (Seelig, 1966) , although in some cases it may come from the respiratory system or heart (Geiger, Wenner, Axilrod, and Durlacher, 1946) . The means by which spores gain access to the circulation depends upon underlying conditions. According to Seelig (1966) , surfaces in contact with proliferating organisms are more likely to be penetrated by the fungus when their integrity is compromised. Thus alterations in the mucous membrane surface by inflammation, surgical trauma, local irritation from antibiotics or Candida toxin, facilitate the penetration of the fungus into the blood stream.
Microscopically, the organism provokes inflammation of the affected cerebral or meningeal blood vessels. These vessels subsequently become congested and thrombosis may occur with infarction of surrounding tissue. At the site of cerebral infarction, necrosis, haemorrhage, and infiltration with microglia and macrophages may occur along with proliferation of astrocytes. Fungi can often be seen within the infarcted area. Later, abscess or granuloma formation occur, although frequently these lesions are small and often noted only on microscopic examination. Multinucleated giant cells may be present in the granulomas.
Exactly how the fungi destroy tissue or cells is unknown, but there is evidence that the organism may release a toxin. The exact nature of this toxic substance has not been defined chemically or immunologically. Further information about this substancecan befound in thereview by Friedman (1965) . TREATMENT Favourable results have been reported after therapy with iodides (Bogen and Kessel, 1937; Zimmerman et al., 1947; Rezza, 1950; Emdin and Finlayson, 1954) , sulphonamides (Fine, Franklin, and Lieberthal, 1955) , streptomycin (Levi and Rezza, 1950; Nalenz and Boese, 1951; Carron and Chavanis, 1954) , propylparaben (Gessler and Laux, 1957; Janke, 1957) , and nystatin (Debre, Lelong, Mozziconacci, and Robineau, 1957; Luyendijk, Welman, and Cormane, 1959) . However, amphotericin B is now the drug of choice in this disease (DeVita, Utz, Williams, and Carbone, 1966) .
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This drug is a polyene antibiotic which acts by interfering with the function of the cytoplasmic membrane of fungal cells. The current theory is that the antibiotic binds with certain sterols in the cellular membrane causing leakage of cytoplasmic contents and impairment of fungal cell metabolism (Utz, 1964) . The drug is fungistatic and a total intravenous dose of approximately 2 to 3 g is necessary for therapeutic benefit.
The patient reported in this paper received 30 to 50 mg intravenous amphotericin B every other day to a total of 430 mg. However, despite this therapy, her neurological status worsened while her blood urea nitrogen rose to 36 mg/100 ml. Consequently an Ommaya reservoir was inserted into the right lateral ventricle of the brain through which amphotericin could be injected. The decision to insert the reservoir was based on the evidence that only small amounts of the drug cross the blood cerebrospinal fluid barrier (Louria, 1958) . It was also felt that the reservoir permitted more prolonged and higher peaks of intracerebral amphotericin than would have been possible with the lumbar or intravenous route alone. The recommended intraventricular dose of amphotericin is 0 3 to 1-0 mg daily or every other day depending upon patient tolerance. An initial intraventricular dose of 1-0 mg was administered to our patient.
There seemed to be a causal relationship between the intraventricular injection and the patient's subsequent worsening neurological status. Microscopic examination of the meninges revealed an acute meningitis but no evidence of granuloma or PAS positive staining fungi. This raises the possibility of a meningitis caused by the amphotericin itself. Chemical meningitis as a result of lumbar intrathecal injections of amphotericin rarely occurs (Spickard, Butler, Andriole, and Utz, 1963) , but the incidence of meningitis after intraventricular injections has never been recorded. Perhaps the dosage of the initial injection is an important contributing factor in the formation of the acute meningeal inflammation. It may well be that 1 mg amphotericin was an excessive initial intraventricular dose for our patient.
AETIOLOGY Debilitating disease, antibiotic therapy, and adrenocortical hormones acting either alone or in combination seem to predispose to disseminated candidiasis. There is at present no explanation for this predisposition, but it seems probable that the infection is related in some way to suppression of normal immunity mechanisms.
Occasionally central nervous system candidiasis occurs in patients in whom no predisposing medication or illness can be found. The aetiology of the infection in these individuals is not clear, but it may be related in part to the virulence of the infecting strain of Candida albicans (Louria et al., 1962) . The mechanism of tissue localization in these individuals is also uncertain, but there is some experimental evidence that suggests that certain strains and species of Candida have a predilection for brain tissue. Smith and Sano (1933) studied a strain of Candida albicans acquired from the brain of one patient and reported that it was neurotropic when injected into rabbits. Also Louria et al. (1962) showed that certain species of Candida regularly produced central nervous system infection in mice after intravenous injection. However, despite the fact that certain strains and species of Candida seem neurotropic in experimental animals, no conclusions can be drawn concerning the possibility that the course and tissue localization of human candidiasis is related to characteristics of the invading strain of Candida organisms (Louria et al., 1962) .
It may also be argued that apparently healthy individuals who develop such dissemination actually suffer from a specific immunological or enzymatic defect which does not ordinarily manifest itself as an impairment in general health. Recently, Lehrer and Cline (1969) discovered that the neutrophils and monocytes of an otherwise healthy patient afflicted with disseminated Candida albicans infection lacked detectable levels of the lysosomal enzyme myeloperoxidase. They concluded that this enzyme was specifically necessary for the killing of Candida organisms by human white blood cells after phagocytosis. However, disseminated candidiasis due to a specific susceptibility engendered by the lack of leukocyte myeloperoxidase is unlikely in our patient, for she had a normal amount of this enzyme in her neutrophils. There is the possibility that our patient lacked another, as yet undelineated, neutrophilic enzyme that is specifically necessary for candidacidial activity.
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